Opportunity
Saskatchewan Tenders #PS27-POM-LEN-RFP
Procurement of Lenalidomide and Pomalidomide Oral Oncology Medications
Posted
June 05, 2026
Respond By
July 14, 2026
Identifier
PS27-POM-LEN-RFP
NAICS
424210
This opportunity is a national procurement led by HealthPRO Procurement Services Inc., in partnership with 3sHealth, for oncology oral solid medications. - Government Buyer: - HealthPRO Procurement Services Inc. (in association with 3sHealth) - Products/Services Requested: - Lenalidomide oral solid medication - Pomalidomide oral solid medication - Both products are requested in oral solid form; no specific part numbers or quantities are provided - OEMs and Vendors Mentioned: - HealthPRO Procurement Services Inc. (buyer) - 3sHealth (partner) - Unique/Notable Requirements: - Estimated contract value is approximately $15,021,568 - Contract term is three years, with two optional one-year extensions - All bidders must agree to HealthPRO Canada Contract Terms and Conditions - Opportunity is open to all qualified suppliers; communications must be in English
Description
HealthPRO Procurement Services Inc. has issued a Request for Proposal (RFP) for oncology oral solid medications, specifically Lenalidomide and Pomalidomide. The contract cycle code is PS27, and the contract term is from June 1, 2027, to May 31, 2030, with an option for two additional one-year terms. The estimated contract value is approximately $15 million. Bidders must agree to HealthPRO Canada Contract Terms and Conditions and submit proposals electronically by July 14, 2026.